Zhuhai Trinomab Pharmaceutical Co., Ltd.

This study is testing a new injection called siltartoxatug to prevent tetanus in people who have had an injury. Researchers will track 10,000 participants for 90 days to see if the shot stops tetanus from developing. The study also monitors for side effects.